EP
AXGN icon

Essential Partners’s Axogen AXGN Stock Holding History

Essential Partners’s Portfolio AXGN Stock Details AXGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$42 Hold
1
– – ﹤0.01% 2780
2026
Q2 		$46 Hold
1
– – ﹤0.01% 2797
2026
Q1 		$33 Hold
1
– – ﹤0.01% 2803
2025
Q4 		$33 Buy
+1
New +$25 ﹤0.01% 2686

Other funds holding AXGN

AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return
MWM
MFG Wealth Management Indianapolis, Indiana $138M AUM 31.54% 1-Year Est. Return
HCA
Harbour Capital Advisors Tysons Corner, Virginia $548M AUM 37.76% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.8B AUM 12.84% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

Essential Partners's AXGN Position: Q3 2026 in Review

Essential Partners held its Axogen (AXGN) position steady in Q3 2026 at 1 share worth $42. The position accounts for ﹤0.01% of the portfolio, ranked #2780.

Essential Partners first reported a position in AXGN in Q4 2025 and has held it in 4 quarters since. The position peaked at $46 in Q2 2026. 11 funds tracked by Wall St. Rank hold AXGN as of Q3 2026.

  • Essential Partners held 1 share of Axogen worth $42 as of Q3 2026.
  • Essential Partners left its Axogen share count unchanged in Q3 2026.
  • Axogen made up ﹤0.01% of Essential Partners's portfolio in Q3 2026, its #2780 holding.
  • Essential Partners first reported a position in Axogen in Q4 2025 and has held it in 4 quarters since.
  • Essential Partners's Axogen position peaked at $46 in Q2 2026.
  • 11 funds tracked by Wall St. Rank held Axogen as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.